NCT02526888View on ClinicalTrials.gov

Pharmacokinetic Interaction Between Diltiazem and ACT-541468 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

November 1, 2015

Study Completion Date

November 1, 2015

Conditions
Healthy Subjects
Interventions
DRUG

ACT-541468

Oral capsule (25 mg) as single dose

DRUG

Diltiazem

Two oral capsules (2 x 120 mg) once daily from Day 1 to Day 7

Trial Locations (1)

24105

CRS Clinical Research Services Kiel GmbH, Kiel

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY